Gilead Sciences Inc (GILD)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 5,665,000 | 4,592,000 | 6,225,000 | 123,000 | 5,386,000 |
| Revenue | US$ in thousands | 26,229,000 | 26,413,000 | 26,325,000 | 24,689,000 | 22,449,000 |
| Net profit margin | 21.60% | 17.39% | 23.65% | 0.50% | 23.99% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $5,665,000K ÷ $26,229,000K
= 21.60%
The net profit margin of Gilead Sciences, Inc. has shown varying trends over the past five years. In 2019, the net profit margin was at its highest at 23.99%, indicating that for every dollar in revenue generated, the company retained approximately 23.99 cents as profit. This was followed by a significant drop in 2020 to 0.50%, which suggests a substantial decrease in profitability, possibly due to extraordinary expenses or one-time charges.
In 2021, the net profit margin significantly rebounded to 22.80%, indicating improved profitability and efficiency in managing costs relative to revenue. The trend continued in 2022, with a net profit margin of 16.83%, although lower than the previous year but still reflecting a reasonably healthy level of profitability.
By the end of 2023, Gilead Sciences, Inc. saw a further improvement in its net profit margin, reaching 20.89%. This may indicate continued efforts to enhance operational efficiency, control costs, or increase revenue generation.
Overall, the fluctuating net profit margin of Gilead Sciences, Inc. over the years suggests varying levels of profitability and efficiency in utilizing resources to generate earnings. Investment analysts and stakeholders may further evaluate the company's strategies and financial performance to gauge its sustainability and growth potential.
Peer comparison
Dec 31, 2023